A detailed history of Davis Investment Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Davis Investment Partners, LLC holds 5,600 shares of ABT stock, worth $639,688. This represents 0.27% of its overall portfolio holdings.

Number of Shares
5,600
Previous 5,778 3.08%
Holding current value
$639,688
Previous $602 Million 5.68%
% of portfolio
0.27%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$100.07 - $118.13 $17,812 - $21,027
-178 Reduced 3.08%
5,600 $636 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $549,256 - $644,362
5,778 New
5,778 $627 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Davis Investment Partners, LLC Portfolio

Follow Davis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davis Investment Partners, LLC with notifications on news.